In elucidating and validating the mechanisms of action of drugs, bioinformatics utilizes technologies such as NP, molecular docking and MD simulation to simulate interactions between drugs and targets, constructing drug-target networks, predicting drug action targets and pathways, and further analyzing mechanisms of action, providing theoretical support for drug development and clinical applications (Dahl et al., 2002
Clinical and biomarker changes in dominantly inherited Alzheimers disease
Arthur Beaudet has been following clinical and genetic clues in patients with autism spectrum disorder and experimental results in animal models that have led him to propose that the lack of carnitine, a nutrient needed for the normal development and workings of the brain, the liver, the heart and other muscles, might be involved in triggering mild forms of autism
noted local recurrences in only 1 of 28 patients with follow-up
65/24, Dec 2024)
An enzyme called Carnitine Palmitoyltransferase I (CPT1), located on the outer mitochondrial membrane, attaches a molecule of L-carnitine to the long-chain fatty acid, creating an acylcarnitine complex
